Sex Subgroup Analysis of Treatment Response to Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder

被引：0
|
作者：
McGough, James J. [1 ,2 ]
Greenbaum, Michael [3 ]
Adeyi, Ben [4 ]
Babcock, Thomas [4 ]
Scheckner, Brian [4 ]
Dirks, Bryan [4 ]
Findling, Robert L. [5 ]
机构：
[1] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Capstone Clin Res, Libertyville, IL USA
[4] Shire Dev Inc, Wayne, PA USA
[5] Univ Hosp Case Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2012年 / 32卷 / 01期
关键词：
CLINICAL-TRIALS; MODERATORS; ADHD;
D O I：
10.1097/JCP.0b013e318240dc53
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：138 / 140
页数：4
相关论文
共 50 条
  • [1] Long-term safety and tolerability of lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder
    Findling, Robert L.
    Lopez, Frank A.
    Childress, Ann C.
    Krishnan, Suma
    McGough, James
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 875 - 875
  • [2] Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
    Childress, Ann C.
    Findling, Robert L.
    Wu, James
    Kollins, Scott H.
    Wang, Yi
    Martin, Patrick
    Robertson, Brigitte
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (03) : 128 - 136
  • [3] Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: A secondary analysis
    Lopez, Frank A.
    Ginsberg, Lawrence D.
    Arnold, Valerie
    POSTGRADUATE MEDICINE, 2008, 120 (03) : 89 - 102
  • [4] Efficacy and safety of lisdexamfetamine dimesylate [LDX; NRP104] in children aged 6 to 12 years with attention-deficit/hyperactivity disorder
    Biederman, Joseph
    Mandler, Hilary
    Krishnan, Suma
    Findling, Robert L.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2006, 27 (05): : 443 - 443
  • [5] Lisdexamfetamine Dimesylate In Attention-Deficit Hyperactivity Disorder in Adults
    Weber, Juliane
    Siddiqui, M. Asif A.
    CNS DRUGS, 2009, 23 (05) : 419 - 425
  • [6] Long-term effectiveness and safety of lisdexamfetamine dimesylate in children aged 6-12 with attention-deficit/hyperactivity disorder
    McGough, J.
    Childress, A.
    Krishnan, S.
    Findling, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S559 - S559
  • [7] Clinical Response and Symptomatic Remission in Children Treated With Lisdexamfetamine Dimesylate for Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Adeyi, Ben
    Chen, Gary
    Dirks, Bryan
    Babcock, Thomas
    Scheckner, Brian
    Lasser, Robert
    Pucci, Michael L.
    Abdullah, Huda I.
    McGough, James J.
    CNS SPECTRUMS, 2010, 15 (09) : 559 - 568
  • [8] Lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder: pharmacokinetics, efficacy and safety in children and adolescents
    Mattos, Paulo
    REVISTA DE PSIQUIATRIA CLINICA, 2014, 41 (02): : 34 - 39
  • [9] An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder
    Wigal, Sharon B.
    Raja, Pooja
    Shukla, Ankita
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 137 - 145
  • [10] EFFECT OF LISDEXAMFETAMINE DIMESYLATE ON FUNCTIONAL IMPAIRMENT IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Soutullo, C. A.
    Banaschewski, T.
    Lecendreux, M. L.
    Bloomfield, R.
    Hodgkins, P.
    Coghill, D. R.
    EUROPEAN PSYCHIATRY, 2012, 27
12345